Introduction
Periostin, a matricellular protein, is associated with normal development of teeth, bone, heart, and kidney during the embryonic period [1] [2] [3] , but thereafter, its expression has been associated with congestive heart failure [4, 5] , myocardial infarction [6, 7] , muscle injury, asthma [8] , and development and metastasis of various malignancies [9] [10] [11] . In addition, previous clinical and experimental studies have reported that periostin was highly expressed in fibrotic tissues [12, 13] and associated with disease severity in several chronic kidney disease (CKD) models such as diabetic nephropathy or hypertensive nephropathy [14] .
Periostin primarily binds to integrin, and crosstalk with receptor tyrosine kinases, such as epidermal growth factor receptor in the plasma membrane, is observed. Then, it activates the AKT-or FAK-mediated signaling pathway and regulates various cell functions, including cell adhesion, mobility, migration, survival, proliferation, and angiogenesis [15] . Moreover, is binds extracellular matrix molecules, such as collagen IV and fibronectin, which leads to extracellular matrix remodeling, organization, fibrillogenesis, and epithelial-mesenchymal transition [16] [17] [18] .
Acute kidney injury (AKI) occurs in 5-10% of hospitalized patients and in more than 30% of critically ill patients [19] . The incidence of AKI has increased every year [19] , which has major direct and indirect clinical implications. AKI results in impeded treatment for comorbidities, increased risk of acute renal replacement therapy, longer hospital stays, increased burden of medical costs, and increased mortality rates (up to 50-80%) [20, 21] .
Furthermore, AKI patients showed a higher risk of progression to CKD [22] , which was substantial when the AKI patients experienced more episodes and more severe injury [23, 24] . Recently, it was reported that severe AKI patients requiring continuous renal replacement therapy (CRRT) had a greater risk of progression to end-stage renal disease compared to that of stage 3 CKD patients who did not undergo an AKI episode, even if their renal function recovered at 3 months [25] .
Similarly, periostin plays a crucial role in the fibrosis in diverse organs, including the kidney; however, the association between the progression of AKI to CKD and periostin has not been investigated. In the present study, a "progression of AKI to CKD model" was established and the effects of periostin were analyzed. Then, whether the inhibition of periostin was a protective factor for progression of AKI to CKD were investigated.
Experimental animals
Male wild-type (WT) mice (C57BL/6; B6) were purchased from Koatech (Seoul, Korea) and male periostin (Postn) null mice (Postn -/-) (B6;129-Postn tm1Jmol /J) [26] were purchased from the Jackson Laboratory (Bar Harbor, ME, USA). All of the 7-to 8-week-old mice used in the experiments were raised in a specific pathogen-free animal facility. All 
Establishment of progressive kidney injury in vivo model
A "progression of AKI to CKD model" was designated as the "progressive kidney injury model". Firstly, to establish a progressive kidney injury in vivo model, unilateral ischemia-reperfusion injury (UIRI) was induced in the left kidney pedicle for 30 minutes in WT mice and Postn null mice. The mice were anesthetized with xylazine (Rompun; 10 mg/kg; Bayer, Canada) and tiletamine mixed with zolazepam (1:1) (Zoletil TM ; 30 mg/kg; Virbac, USA). After unilateral flank incision, the left renal pedicle was cross-clamped for 30 minutes with microaneurysm clamps (Roboz Surgical Instrument Co., Gaithersburg, MD), and then, reperfusion was performed. During the procedure, pre-warmed (37°C) PBS (500 µl) was administered intraperitoneally for optimal fluid balance, and the animals were placed on a heating pad (37°C). Sham-operated mice received the same surgical procedure except for the clamping of renal pedicle. After 6 weeks, mice were sacrificed, and blood, urine, and kidney tissues were obtained.
Gross features and the weights of both kidneys were examined, and the weight ratios of left kidney to right kidney were analyzed.
Establishment of progressive kidney injury in vitro model
For the progressive kidney injury in vitro model, a "hypoxia induced O 2 , 5% CO 2 , and 74% N 2 , which was used as a positive control. For hypoxia induction, HK-2 cells also were subjected to a hypoxic incubator (5% O 2 , 5% CO 2 , and 90% N 2 ). Under this condition, after 24 hours, the expression of phosphorylated p38 mitogen-activated protein kinase (phospho-p38 MAPK) was observed as an acute response of hypoxia; then, fibrosis was induced via hypoxia injury for 5 days. Moreover, to assess the protective effect on fibrosis, the cells were pre-treated for 1 hour and cultured with a p38 MAPK inhibitor (SB-731445) [27] , supplied by GSK Global (Hertfordshire, UK), at concentrations of 1 and 2 µM, in the hypoxic incubator for 5 days.
Histological analyses
For histological analyses, 4 µm-thick paraffin sections were stained with 
Confocal microscopic examination
To detect the expression of phospho-p38 MAPK, the sections were 
Quantitative real-time PCR
Total RNA was isolated from mouse kidney tissues 6 weeks after disease induction, and the mRNA levels were analyzed by real-time PCR. Briefly, 1 µg of total RNA extracted using the RNeasy kit (Qiagen GmBH, Hilden, Germany) was reverse-transcribed using oligo-d(T) primers and AMV-RT Taq polymerase (Promega, Madison, WI, USA). Real-time PCR was performed using either an Assay-on-Demend TaqMan probes or the SYBR Green method and primers for α-smooth muscle actin (α-SMA), fibronectin, collagen 1A1, periostin, TGF-β1, p53, caspase-9, glycogen synthase kinase 3β (GSK3β), p38 MAPK, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Applied Biosystems, Foster City, CA, USA) with an ABI PRISM 7500 Sequence Detection System. Relative quantification was done using the ΔΔCT method. The mRNA expression levels were normalized using the GAPDH mRNA expression.
Western blot analyses
Kidney tissues were harvested from mice 6 weeks after disease induction, 
Statistics
The results are expressed as the mean ± standard deviation or the median (interquartile ranges) based on the results of the Shapiro-Wilk normality test.
Student's t-test or the Mann-Whitney U test was used according to their normality. For comparison of more than two groups, one-or two-way ANOVA using Tukey's test was performed. Statistical analyses were performed using SPSS version 22 (IBM software, USA) and GraphPad Prism 5.0 (GraphPad Software, Inc., San Diego, CA, USA). Statistical significance was determined at P < 0.05.
In the progressive kidney injury model, fibrosis was attenuated in periostin null mice.
To determine the role of periostin in the progression of AKI to kidney fibrosis (designated as "progressive kidney injury"), UIRI was induced in WT mice and Postn null mice and the animals were observed for 6 weeks. In the progressive kidney injury model, apoptosis was decreased in periostin null mice.
Firstly, to verify the relationship between progressive kidney injury and apoptosis, the expression of cleaved caspase-3 was examined in the kidney tissues 6 weeks after disease induction ( Figure 3A) . The highly expressed cleaved caspase-3 in WT mice was significantly decreased in Postn null mice. Next, mRNA and protein levels of apoptosis markers were quantified using real-time PCR and western blot analyses ( Figure 3B) . Caspase-9, GSK3β, and p53 (WT sham vs. WT UIRI vs. Postn null UIRI 1.00 ± 0.09 vs. 2.77 ± 0.92 vs. 1.44 ± 0.67; P < 0.001) substantially increased in WT mice along with the development of progressive kidney injury compared to those in Postn null mice. In contrast, the expression of Bcl-2 was higher in
Postn null mice than that in WT mice.
(B) The mRNA and protein levels of apoptosis markers. Caspase-9, GSK3β, and p53 were significantly increased in WT compared to those in Postn null mice; however, Bcl-2 was higher in Postn null mice than that in WT mice (n = 10/group; *P < 0.05, **P < 0.01, ***P < 0.001). Data are shown as mean ± standard deviation and Student's t-test was used. These results represent one of three independent experiments.
Inhibition of p38 MAPK ameliorated hypoxia-induced fibrosis.
Further, the role of p38 MAPK inhibition was demonstrated using in vivo MAPK was significantly elevated in WT mice compared to that in control mice and was, significantly decreased in Postn null mice (n = 10/group; **P < 0.01, ***P < 0.001) Data are shown as mean ± standard deviation and Student's t-test was used.
These results represent one of three independent experiments. Second, for in vitro studies, the early expression of phospho-p38 MAPK was confirmed through confocal microscopic examination ( Figure 5A ). The HK-2 cells incubated in hypoxic conditions for 24 hours increased phospho-p38 MAPK expression, which was similar to the results following treatment with rTGF-β1 under normoxic conditions. Furthermore, hypoxia in combination with rPeriostin significantly magnified the expression of phospho-p38 MAPK, which was also comparable to that following treatment with rTGF-β1 under hypoxia. injury for 24 hours resulted in phospho-p38 MAPK expression, which was comparable to that with rTGF-β1 under normoxia. In addition, the expression of phospho-p38 MAPK under hypoxia was substantially augmented by the administration of rPeriostin, which was comparable to that with rTGF-β1 under hypoxia (**P < 0.01, ***P < 0.001; magnification: ×800).
Finally, to confirm the hypothesis that p38 MAPK inhibition affected fibrosis markers, HK-2 cells cultured with rTGF-β1 at normoxic condition and with a p38 MAPK inhibitor at hypoxic condition were harvested after 5 days. Hypoxia injury enhanced the fibronectin, collagen 1A1, α-SMA, periostin, and snail expressions comparable to or much greater than those following treatment with rTGF-β1 under normoxia; however, these expressions were substantially mitigated by the use of the p38 MAPK inhibitor (dose-dependent). In contrast, decreased E-cadherin expression under hypoxia injury was significantly augmented by p38 MAPK inhibition ( Figure   5B ).
(B) Western blot analysis. HK-2 cells were cultured with rTGF-β1 at normoxic conditions and with a p38 MAPK inhibitor in hypoxic conditions. After 5 days, the expression of fibronectin, collagen 1A1, α-SMA, periostin, and snail following hypoxia injury were observed, which were comparable to or much greater than that
Discussion
In this study, an experimental model of the progression from AKI to CKD was established and the association between periostin and this model was investigated. The protective effects of periostin suppression and a correlation with the p38 MAPK pathway were also identified.
The unilateral IRI in vivo model established in this study represented the progression to CKD after 6 weeks following AKI induced by ischemia and hypoxic injury, which has become an important issue recently [28] . This experimental model is relevant due to the clinical importance of progression from AKI to CKD.
In a previous study, periostin mRNA expression in tissues was expressed in inverse proportion to renal function of the patients with various kidney diseases accompanied with tubulo-interstitial fibrosis or glomerular injury [12] . In addition, the mRNA level of periostin was significantly associated with proteinuria, serum Cr level, and renal blood flow in a hypertensive nephropathy rat model [14] . Suppression of p38 MAPK decreased inflammation and necrosis, and improved microvascular function and coronary blood flow, which resulted in an improvement in interstitial and perivascular fibrosis [38, 39] . In an 
